Researchers Question One-Size-Fits-All COVID Booster Strategy as FDA Circumvents Advisors

Federal health officials face a growing hurdle in their quest to persuade Americans of all ages and risk profiles to get updated COVID-19 boosters: strong proponents of vaccination.

From New England to the Bay Area, researchers voiced concerns to mainstream science and health publications in recent days that the one-size-fits-all model may be backfiring.

Read More

Pfizer CEO Calls for Another Booster Shot for All Americans

On Sunday, the chief executive officer of Pfizer said that Americans should be prepared to receive a second booster shot of the Coronavirus vaccine, which would mark the fourth overall shot that has been forced on the American public.

As reported by Politico, Albert Bourla made his remarks in an interview with CBS’ Margaret Brennan, where he said that his company was preparing to submit “a significant package of data about the need for a fourth dose” to the Food and Drug Administration (FDA).

Read More

Two Minnesota Colleges Requiring Booster Shots for Spring Semester

Two Minnesota colleges have joined a handful of schools across the country who will require students to receive a COVID-19 booster shot in order to attend spring semester classes.

“News about the new Omicron variant of the COVID-19 virus is undoubtedly on all of our minds, particularly as we spend more time indoors and in close proximity with loved ones over the winter break. While we don’t yet know how this new variant might impact our community, we are paying close attention to its development and will be ready to adjust plans on campus if needed,” Carleton College said on its website. 

Read More

FDA Approves Moderna and Pfizer Boosters for Adults

The Food and Drug Administration (FDA) approved Moderna and Pfizer’s COVID-19 vaccines for booster shot use for adults in the U.S., the agency announced Friday,

The announcement was made just two months after the FDA first rejected the White House’s plan to administer booster shots to all adults the week of Sept. 20. FDA Acting Commissioner Janet Woodcock approved the booster without holding the usual public meeting to review the data, and the Centers for Disease Control and Prevention (CDC) will meet Friday afternoon to discuss the authorization, according to the FDA press release.

“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Woodcock said in the press release.

Read More